RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Data from 8910 patients 👇 "ACE-I/ARBs were not associated with an increased risk of in-hospital death but the underlying cardiovascular disease was increased risk" @MRMehraMD et al. @NEJM #COVID19 @OncoAlert @ichastaliklari @AnkaraUni @American_Heart ht
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
Blocage des récepteurs ACE2 par les IEC sans effet sur le covid19 https://t.co/LcAMr4RDFv
RT @DocteurJuneau: Important: 4 articles ds le NEJM sur les IECA et ARA . Pas d'effets négatifs sur l'infection au COVID19. Rassurant pour…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @DanielJDrucker: “Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/AMB2d9SDWv
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @catcardiocamfic: Més evidències encara de que el tractament amb IECA/ARA2 en pacients amb HTA i #COVID19 no té efecte perjudicial i, pe…
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @catcardiocamfic: Més evidències encara de que el tractament amb IECA/ARA2 en pacients amb HTA i #COVID19 no té efecte perjudicial i, pe…
From @MRMehraMD and colleagues, a new paper in @NEJM explores the intersection of cardiovascular disease, medications and COVID-19. https://t.co/H16D2mOc0t
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @PharmERToxGuy: Three new large population studies in @NEJM find ACE-Inhibitors and ARBs do NOT increase risk of #COVID19. Cardiovascula…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/qKzX8nzTZn
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Vore trevligt om det kunde bli en lika fet kvällstidningsrubrik om att det är säkert, som när det kom spekulationer om att det inte var det, @Expressen & @Aftonbladet!
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @MRMehraMD: Many Questions, Varying Opinions, now some data-driven answers - How do Cardiac Medications modify outcome in COVID-19? Card…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @TamiMartino: Fascinating turn... No evidence for for adverse affects of ACE or ARBs on Covid-19 pathogenesis / pathophysiology.
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
Good News for nephrologists
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Some good news on Covid-19 and possible interactions of ACE inhibitors https://t.co/iPhyoASDbC
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
The 3‼️ @NEJM papers today answer all the bluster around #ACEi #ARBs in #COVID19 - bottom line, they don’t seem to worsen disease. Summary tables for all 👇 https://t.co/P5R0KKl71u https://t.co/72tbjgkLxp https://t.co/djbnB3dnIf But before you get too excit
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Fascinating turn... No evidence for for adverse affects of ACE or ARBs on Covid-19 pathogenesis / pathophysiology.
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DavidJuurlink: Three new studies in @NEJM on the safety of ACE inhibitors/ARBs in COVID-19 https://t.co/kFfescrB6f https://t.co/YXbFw…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Study finds ACEI not associated with #COVID19 mortality. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/OyYGVSuuNE
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
@brunobd11 @dumanhaydar @lordmahammer https://t.co/YA05zpz47O Pas dangereux vous dites ?
Age >65, coronary artery disease, CHF, cardiac arrhythmia, COPD, & current smoking were associated w a higher risk of death in COVID19 Female sex, use of ACE inhibitors & statins were associated with a better chance of survival to hospital disch
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
“Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death” #COVID19 https://t.co/5HwwsXz5ww
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
@BelleudiV
RT @DocteurJuneau: Important: 4 articles ds le NEJM sur les IECA et ARA . Pas d'effets négatifs sur l'infection au COVID19. Rassurant pour…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @MRMehraMD: No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating find…
RT @AndyBiotech: Three studies in NEJM found no evidence of harm with continued use of ACEi and ARBs in #COVID19 pts w/ hypertension N=891…
RT @GilbertDeray: Les barres à droite de la ligne verticale indiquent les facteurs qui augmente le risque de mortalité intra hospitalière.…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Pas de sur risque #COVID19 chez les patients traités par inhibiteurs de l’enzyme de conversion (ACE en anglais), ni par antagoniste/inhibiteurs des récepteurs de l'angiotensine II (ARB)